Introduction
Safe Beta Trio is a prescription medication that combines three active ingredients: Cilnidipine, Metoprolol Succinate, and Telmisartan. It is commonly prescribed by healthcare professionals for the treatment of certain cardiovascular conditions.
Uses
Safe Beta Trio is primarily used to manage hypertension (high blood pressure) in patients who require multiple medications to control their blood pressure. It can also be prescribed for patients with certain heart conditions, such as angina (chest pain) or heart failure, when these conditions are associated with high blood pressure.
Dosage and Administration
The dosage of Safe Beta Trio will be determined by your healthcare professional based on your specific medical condition and response to treatment. Follow their instructions carefully. The tablets are usually taken orally with water, and can be taken with or without food. Do not crush or chew the tablets, as this may affect their effectiveness.
Mechanism of Action
Safe Beta Trio works through a combination of its active ingredients. Cilnidipine is a calcium channel blocker that helps to relax and widen the blood vessels, reducing blood pressure. Metoprolol Succinate is a beta-blocker that helps to slow down the heart rate and reduce the workload on the heart. Telmisartan is an angiotensin II receptor blocker that helps to further lower blood pressure by preventing the narrowing of blood vessels.
Side Effects
Common side effects may include dizziness, headache, fatigue, and swelling of the ankles. These side effects are usually mild and temporary. However, if you experience any serious side effects such as difficulty breathing, chest pain, or irregular heartbeat, seek immediate medical attention.
Drug Interactions
Safe Beta Trio may interact with other medications, including certain blood pressure medications, diuretics, and nonsteroidal anti-inflammatory drugs (NSAIDs). Inform your healthcare professional about all the medications you are currently taking, including over-the-counter medications and herbal supplements, to avoid any potential drug interactions.
Precautions
Before starting Safe Beta Trio, inform your healthcare professional about any allergies or medical conditions you have, especially if you have a history of heart problems, liver or kidney disease, or diabetes. This medication may not be suitable for everyone, and your healthcare professional will consider these factors before prescribing it to you.
Storage
Patient Tips
- Take Safe Beta Trio exactly as prescribed by your healthcare professional. Do not change the dosage or stop taking the medication without consulting them first.
- continue taking this medication even if you feel well, as high blood pressure often has no symptoms. Regular monitoring of your blood pressure is recommended.
- If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and resume your regular dosing schedule.
- Follow a healthy lifestyle, including a balanced diet, regular exercise, and stress management, to complement the effects of the medication and maintain good overall cardiovascular health.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Metoprolol: medicine for high blood pressure (hypertension) (NHS UK) [Accessed 3 Jun. 2024] (online) Available at:
- Micardis 40 mg tablets (Health Professionals SmPC) Available at:
- Cilnidipine (International database) (Drugs.com) [Accessed 2 Jun. 2024] (online) Available at:
- telmisartan (micardis) (RX) [Accessed 27 Jun. 2024] (online) Available at:
- High Blood Pressure (Food and Drug Administration) [Accessed 13 Jun. 2024] (online) Available at:
- Chakraborty RN, Langade D, More S, Revandkar V, Birla A. Efficacy of Cilnidipine (L/N-type Calcium Channel Blocker) in Treatment of Hypertension: A Meta-Analysis of Randomized and Non-randomized Controlled Trials. Cureus. 2021 Nov 22;13(11):e19822. doi: 10.7759/cureus.19822. eCollection 2021 Nov. [Accessed 8 Jun. 2024] Available at:
Reviews
There are no reviews yet.